XML 274 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Basis of Presentation and Recent Accounting Standards (Tables)
9 Months Ended
Sep. 30, 2020
Accounting Policies [Abstract]  
Effect of Adoption of 842 on Condensed Financial Statements
The following tables summarize the effects of adopting ASC 842 on our condensed consolidated financial statements for the three and nine months ended September 30, 2019 (in thousands, except per share data):

Three Months Ended September 30, 2019Nine Months Ended September 30, 2019
ASC 842ASC 842
Previously reportedAdjustmentsAs adjustedPreviously reportedAdjustmentsAs adjusted
Operating expenses:
Research and development $119,715 $(78)$119,637 $378,786 $(431)$378,355 
General and administrative28,188 (15)28,173 83,994 (81)83,913 
Total operating expenses147,903 (93)147,810 462,780 (512)462,268 
Loss from operations(130,857)93 (130,764)(416,626)512 (416,114)
Other expense, net(1,767)(114)(1,881)(5,351)(338)(5,689)
Loss before benefit from income taxes(123,372)(21)(123,393)(391,431)174 (391,257)
Net loss(123,194)(21)(123,215)(390,905)174 (390,731)
Net loss per share attributable to common stockholders, basic and diluted(0.37)— (0.37)(1.19)— (1.19)
Nine Months Ended September 30, 2019
Previously reportedASC 842 Adjustment during the periodAs adjusted
Operating activities
Net loss$(390,905)$174 $(390,731)
Depreciation and amortization22,082 (36)22,046 
Prepaid expenses and other assets(1,407)3,220 1,813 
Right-of-use assets, operating leases— (7,970)(7,970)
Deferred lease obligation3,844 (3,844)— 
Operating lease liabilities— 13,475 13,475 
Other liabilities1,617 (1,770)(153)
Net cash used in operating activities(363,195)3,249 (359,946)
Financing activities
Reimbursement of assets under lease financing obligation3,678 (3,678)— 
Charges to financing lease obligation— 741 741 
Payments on financing lease obligation312 (312)— 
Net cash provided by financing activities23,531 (3,249)20,282 
Components of Accumulated Other Comprehensive Income
The components of accumulated other comprehensive (loss) income for the three and nine months ended September 30, 2020 are as follows (in thousands): 
Unrealized (Loss) Gain on Available-for-Sale Debt Securities
Accumulated other comprehensive income, balance at December 31, 2019
$1,804 
 Other comprehensive loss
(7,931)
Accumulated other comprehensive loss, balance at March 31, 2020(6,127)
Other comprehensive income14,383 
Accumulated other comprehensive income, balance at June 30, 20208,256 
Other comprehensive loss(3,472)
Accumulated other comprehensive income, balance at September 30, 2020$4,784 
Reconciliation of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents and restricted cash in the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows (in thousands):
 
September 30,
20202019
Cash and cash equivalents $1,505,581 $173,711 
Restricted cash1,032 1,032 
Restricted cash, non-current 11,053 10,791 
Total cash, cash equivalents and restricted cash shown in the condensed consolidated
statements of cash flows
$1,517,666 $185,534 
Reconciliation of Restricted Cash
The following table provides a reconciliation of cash, cash equivalents and restricted cash in the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows (in thousands):
 
September 30,
20202019
Cash and cash equivalents $1,505,581 $173,711 
Restricted cash1,032 1,032 
Restricted cash, non-current 11,053 10,791 
Total cash, cash equivalents and restricted cash shown in the condensed consolidated
statements of cash flows
$1,517,666 $185,534